Literature DB >> 24991871

Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation.

Sophocles Chrissobolis1, Grant R Drummond, Frank M Faraci, Christopher G Sobey.   

Abstract

OBJECTIVES: An elevated plasma aldosterone level is an independent cardiovascular risk factor. Although excess aldosterone promotes cardiovascular disease, no studies have examined the effect of increased plasma aldosterone on the cerebral circulation. A major source of vascular reactive oxygen species (ROS) during cardiovascular disease is the NADPH oxidases. Because Nox2-containing NADPH oxidase (Nox2 oxidase) is highly expressed in the cerebral endothelium, we postulated that it might contribute to ROS generation and vascular dysfunction in response to aldosterone. Here, we examined the effect of aldosterone and Nox2 oxidase on ROS production and endothelial dysfunction in the cerebral circulation, and whether the effects of aldosterone are exacerbated in aged mice. METHODS AND
RESULTS: In adult (average age ∼24-25 weeks) wild-type and Nox2-deficient (Nox2(/y)) mice, neither vehicle nor aldosterone (0.28  mg/kg per day for 14 days) affected blood pressure (measured using tail-cuff). By contrast, aldosterone treatment reduced dilation of the basilar artery (measured using myography) to the endothelium-dependent agonist acetylcholine in wild-type mice (P < 0.05), but had no such effect in Nox2(/y) mice (P > 0.05). Aldosterone increased basal and phorbol dibutyrate-stimulated superoxide production (measured using L-012-enhanced chemiluminesence) in cerebral arteries from wild-type but not from Nox2(/y) mice. In aged wild-type mice (average age ∼70 weeks), aldosterone treatment increased blood pressure, but had a similar effect on cerebral artery superoxide levels as in adult wild-type mice.
CONCLUSION: These data indicate that Nox2 oxidase mediates aldosterone-induced increases in ROS production and endothelial dysfunction in cerebral arteries from adult mice independently of blood pressure changes. Aldosterone-induced hypertension is augmented during aging.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24991871      PMCID: PMC4151299          DOI: 10.1097/HJH.0000000000000259

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  50 in total

1.  mPGES-1 deletion impairs aldosterone escape and enhances sodium appetite.

Authors:  Zhanjun Jia; Toshinori Aoyagi; Donald E Kohan; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2010-03-24

2.  Aldosterone alters the participation of endothelial factors in noradrenaline vasoconstriction differently in resistance arteries from normotensive and hypertensive rats.

Authors:  Fabiano E Xavier; Javier Blanco-Rivero; María Soledad Avendaño; Esther Sastre; Rubén Yela; Kyra Velázquez; Mercedes Salaíces; Gloria Balfagón
Journal:  Eur J Pharmacol       Date:  2011-01-22       Impact factor: 4.432

3.  Augmented superoxide production by Nox2-containing NADPH oxidase causes cerebral artery dysfunction during hypercholesterolemia.

Authors:  Alyson A Miller; T Michael De Silva; Courtney P Judkins; Henry Diep; Grant R Drummond; Christopher G Sobey
Journal:  Stroke       Date:  2010-02-18       Impact factor: 7.914

4.  Aldosterone-induced endothelial dysfunction of rat aorta: role of poly(ADP-ribose) activation.

Authors:  Arda Tasatargil; Merih Tekcan; Ciler Celik-Ozenci; Nazli Ece Gungor; Bedriniam Dalkiran
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2009-09       Impact factor: 1.636

5.  Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin.

Authors:  F E Xavier; R Aras-López; I Arroyo-Villa; L del Campo; M Salaices; L V Rossoni; M Ferrer; G Balfagón
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

6.  Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.

Authors:  T Münzel; H Sayegh; B A Freeman; M M Tarpey; D G Harrison
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

Review 7.  Vascular protection: superoxide dismutase isoforms in the vessel wall.

Authors:  Frank M Faraci; Sean P Didion
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-05-27       Impact factor: 8.311

8.  Expression of NAD(P)H oxidase subunits and their contribution to cardiovascular damage in aldosterone/salt-induced hypertensive rat.

Authors:  Young Mee Park; Bong Hee Lim; Rhian M Touyz; Jeong Bae Park
Journal:  J Korean Med Sci       Date:  2008-12-24       Impact factor: 2.153

9.  Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors.

Authors:  Amy McCurley; Paulo W Pires; Shawn B Bender; Mark Aronovitz; Michelle J Zhao; Daniel Metzger; Pierre Chambon; Michael A Hill; Anne M Dorrance; Michael E Mendelsohn; Iris Z Jaffe
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

10.  Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology.

Authors:  Panayiota Papadopoulos; Pedro Rosa-Neto; Joseph Rochford; Edith Hamel
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

View more
  14 in total

Review 1.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

2.  Mineralocorticoid receptor antagonism improves parenchymal arteriole dilation via a TRPV4-dependent mechanism and prevents cognitive dysfunction in hypertension.

Authors:  Janice M Diaz-Otero; Ting-Chieh Yen; Courtney Fisher; Daniel Bota; William F Jackson; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-17       Impact factor: 4.733

3.  Prenatal exposure to methamphetamine in rats induces endothelial dysfunction in male but not female adult offspring.

Authors:  Allison M Harrison; Manoranjan S D'Souza; Sarah L Seeley; Sophocles Chrissobolis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-07       Impact factor: 3.000

4.  PGC1α Regulates the Endothelial Response to Fluid Shear Stress via Telomerase Reverse Transcriptase Control of Heme Oxygenase-1.

Authors:  Shashi Kant; Khanh-Van Tran; Miroslava Kvandova; Amada D Caliz; Hyung-Jin Yoo; Heather Learnard; Ana C Dolan; Siobhan M Craige; Joshua D Hall; Juan M Jiménez; Cynthia St Hilaire; Eberhard Schulz; Swenja Kröller-Schön; John F Keaney
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-11-18       Impact factor: 8.311

5.  Microvascular changes that stagger the mind.

Authors:  Frank M Faraci
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 19.456

6.  Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.

Authors:  Jacqueline N Minas; Max A Thorwald; Debra Conte; Jose-Pablo Vázquez-Medina; Akira Nishiyama; Rudy M Ortiz
Journal:  Clin Exp Pharmacol Physiol       Date:  2015-11       Impact factor: 2.557

Review 7.  Vascular Mineralocorticoid Receptor: Evolutionary Mediator of Wound Healing Turned Harmful by Our Modern Lifestyle.

Authors:  Lauren A Biwer; Mary C Wallingford; Iris Z Jaffe
Journal:  Am J Hypertens       Date:  2019-01-15       Impact factor: 2.689

8.  Small vessels, dementia and chronic diseases - molecular mechanisms and pathophysiology.

Authors:  Karen Horsburgh; Joanna M Wardlaw; Tom van Agtmael; Stuart M Allan; Mike L J Ashford; Philip M Bath; Rosalind Brown; Jason Berwick; M Zameel Cader; Roxana O Carare; John B Davis; Jessica Duncombe; Tracy D Farr; Jill H Fowler; Jozien Goense; Alessandra Granata; Catherine N Hall; Atticus H Hainsworth; Adam Harvey; Cheryl A Hawkes; Anne Joutel; Rajesh N Kalaria; Patrick G Kehoe; Catherine B Lawrence; Andy Lockhart; Seth Love; Malcolm R Macleod; I Mhairi Macrae; Hugh S Markus; Chris McCabe; Barry W McColl; Paul J Meakin; Alyson Miller; Maiken Nedergaard; Michael O'Sullivan; Terry J Quinn; Rikesh Rajani; Lisa M Saksida; Colin Smith; Kenneth J Smith; Rhian M Touyz; Rebecca C Trueman; Tao Wang; Anna Williams; Steven C R Williams; Lorraine M Work
Journal:  Clin Sci (Lond)       Date:  2018-04-30       Impact factor: 6.124

9.  Aldosterone Negatively Regulates Nrf2 Activity: An Additional Mechanism Contributing to Oxidative Stress and Vascular Dysfunction by Aldosterone.

Authors:  Daniel Rodrigues; Tiago J Costa; Josiane F Silva; José Teles de Oliveira Neto; Juliano V Alves; Aline G Fedoce; Rafael Menezes Costa; Rita C Tostes
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

10.  Cell-specific mineralocorticoid receptors: future therapeutic targets for stroke?

Authors:  Quynh N Dinh; Grant R Drummond; Christopher G Sobey; Sophocles Chrissobolis
Journal:  Neural Regen Res       Date:  2016-08       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.